A five-year report on experience in the detection of pheochromocytoma

Clinical Biochemistry

Volumn 33, Issue 8, 2000, Pages 649-655

  Canizares Hernandez F ^a   Sanchez M ^a   Alvarez, A ^a   Diaz J ^a   Pascual, R ^a   Perez M ^a   Tovar, I ^a   Martinez P ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Hypertension; Pheochromocytoma; Total metanephrines; Urinary free catecholamines; Vanillylmandelic acid

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; METADRENALIN; NORADRENALIN; VANILMANDELIC ACID;

ADULT; ARTICLE; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROCHEMICAL ANALYSIS; ENDOCRINE TUMOR; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST; SPAIN; SPECTROPHOTOMETRY; URINALYSIS;

EID: 0034477315     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00172-7     Document Type: Article

References (26)

1. Current concepts. Pheochromocytoma: Diagnosis, localization and management
2. Prevalence of clinically unsuspected pheochromocytoma
3. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma
4. Influence of preoperative treatment with phenoxybenzamine on the incidence of adverse cardiovascular reactions during anesthesia and surgery for pheochromocytoma
5. Laboratory diagnosis of pheochromocytoma: Which analytes should we measure?
6. Plasma and 24-h urinary catecholamine concentrations in normal and patient populations
7. Plasma or urinary metanephrines for the diagnosis of pheochromocytoma? That is the question
8. Plasma metanephrine in the diagnosis of pheochromocytoma
9. The urinary metanephrine-to-creatinine ratio for diagnosis of pheochromocytoma
10. A simple analysis of normetanephrine and metanephrine in urine
11. Quantitative determination of 3-methoxy-4-hydroxymandelic acid (VMA) in urine
12. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
13. Phaeochromocytoma in multiple endocrine neoplasia type 2A: Survey of 100 cases
14. Recent development in the diagnosis and treatment of pheochromocytoma
15. REPAT. Deskop expert system for interpreting and validating laboratory data for pheochromocytoma diagnosis with the database application Omnis 7
16. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications
17. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institutions experience
18. Determination of urinary metanephrines in man using liquid chromatography and electrochemical detection
19. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors
20. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines
21. Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrines and its metabolites in humans
22. The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats
23. Advances in catecholamines and metabolite measurements for diagnosis of pheochromocytoma
24. Plasma normetanephrine and metanephrine for detecting pheochromocytoma and Von Hippel-Lindau disease and Multiple Endocrine Neoplasia type 2
25. Clinical and genetic characterization of pheochromocytoma in Von Hippel-Lindau families: Comparison sporadic pheochromocytoma gives insight into natural history of pheochromocytoma